- Home
- AVIR vs NREF Comparison
AVIR vs NREF Comparison
Compare AVIR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- NREF
- Stock Information
- Founded
- AVIR 2012
- NREF 2019
- Country
- AVIR United States
- NREF United States
- Employees
- AVIR N/A
- NREF N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- NREF Real Estate Investment Trusts
- Sector
- AVIR Health Care
- NREF Real Estate
- Exchange
- AVIR Nasdaq
- NREF Nasdaq
- Market Cap
- AVIR 290.4M
- NREF 264.1M
- IPO Year
- AVIR 2020
- NREF 2020
- Fundamental
- Price
- AVIR $2.97
- NREF $14.20
- Analyst Decision
- AVIR Hold
- NREF Hold
- Analyst Count
- AVIR 1
- NREF 4
- Target Price
- AVIR $6.00
- NREF $14.75
- AVG Volume (30 Days)
- AVIR 223.7K
- NREF 47.1K
- Earning Date
- AVIR 11-06-2025
- NREF 10-30-2025
- Dividend Yield
- AVIR N/A
- NREF 14.31%
- EPS Growth
- AVIR N/A
- NREF N/A
- EPS
- AVIR N/A
- NREF 2.59
- Revenue
- AVIR N/A
- NREF $121,573,000.00
- Revenue This Year
- AVIR N/A
- NREF $27.27
- Revenue Next Year
- AVIR N/A
- NREF $5.40
- P/E Ratio
- AVIR N/A
- NREF $5.40
- Revenue Growth
- AVIR N/A
- NREF 302.49
- 52 Week Low
- AVIR $2.46
- NREF $12.14
- 52 Week High
- AVIR $4.10
- NREF $18.09
- Technical
- Relative Strength Index (RSI)
- AVIR 33.48
- NREF 41.21
- Support Level
- AVIR $2.84
- NREF $13.92
- Resistance Level
- AVIR $3.33
- NREF $15.60
- Average True Range (ATR)
- AVIR 0.14
- NREF 0.36
- MACD
- AVIR -0.04
- NREF -0.17
- Stochastic Oscillator
- AVIR 18.98
- NREF 17.29
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.